{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T03:14:46Z","timestamp":1783480486136,"version":"3.55.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T00:00:00Z","timestamp":1773187200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","euoncology.europeanurology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology Oncology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.euo.2026.03.004","type":"journal-article","created":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T21:36:29Z","timestamp":1774042589000},"page":"638-644","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Monogenic and Polygenic Risk for Kidney Cancer in Two Large Biobanks"],"prefix":"10.1016","volume":"9","author":[{"given":"Jun","family":"Wei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley J.","family":"Mulford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuqing","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huy","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annabelle","family":"Ashworth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Lilly","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jim","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan R.","family":"Sanders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raj","family":"Bhanvadia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristian","family":"Novakovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Conrad","family":"Tobert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Helfand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nirmish","family":"Singla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Lane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1343-8752","authenticated-orcid":false,"given":"Jianfeng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euo.2026.03.004_b0005","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.eururo.2025.06.005","article-title":"Epidemiology of renal cancer: incidence, mortality, survival, genetic predisposition, and risk factors","volume":"88","author":"Larcher","year":"2025","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2026.03.004_b0010","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1001\/jama.2015.17703","article-title":"Familial risk and heritability of cancer among twins in Nordic countries","volume":"315","author":"Mucci","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.euo.2026.03.004_b0015","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/S0094-0143(03)00054-5","article-title":"Hereditary kidney cancer","volume":"30","author":"Hwang","year":"2003","journal-title":"Urol Clin North Am"},{"key":"10.1016\/j.euo.2026.03.004_b0020","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1053\/j.ackd.2013.10.001","article-title":"Hereditary kidney cancer syndromes","volume":"21","author":"Haas","year":"2014","journal-title":"Adv Chronic Kidney Dis"},{"key":"10.1016\/j.euo.2026.03.004_b0025","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1097\/MOU.0000000000000646","article-title":"Inherited kidney cancer syndromes","volume":"29","author":"Ball","year":"2019","journal-title":"Curr Opin Urol"},{"key":"10.1016\/j.euo.2026.03.004_b0030","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1200\/JCO.2013.50.8192","article-title":"Defining early-onset kidney cancer: implications for germline and somatic mutation testing and clinical management","volume":"32","author":"Shuch","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.euo.2026.03.004_b0035","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.euo.2021.09.005","article-title":"Germline variants identified in patients with early-onset renal cell carcinoma referred for germline genetic testing","volume":"4","author":"Truong","year":"2021","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.euo.2026.03.004_b0040","doi-asserted-by":"crossref","first-page":"4363","DOI":"10.1002\/cncr.30893","article-title":"Advances in the diagnosis of hereditary kidney cancer: initial results of a multigene panel test","volume":"123","author":"Nguyen","year":"2017","journal-title":"Cancer"},{"key":"10.1016\/j.euo.2026.03.004_b0045","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1001\/jamaoncol.2018.1986","article-title":"Prevalence of germline mutations in cancer susceptibility genes in patients with advanced renal cell carcinoma","volume":"4","author":"Carlo","year":"2018","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.euo.2026.03.004_b0050","doi-asserted-by":"crossref","first-page":"13518","DOI":"10.1038\/s41598-020-70449-5","article-title":"Prevalence of pathogenic variants in DNA damage response and repair genes in patients undergoing cancer risk assessment and reporting a personal history of early-onset renal cancer","volume":"10","author":"Hartman","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.euo.2026.03.004_b0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.108926","article-title":"Trans-ethnic variation in germline variants of patients with renal cell carcinoma","volume":"34","author":"Abou Alaiwi","year":"2021","journal-title":"Cell Rep"},{"key":"10.1016\/j.euo.2026.03.004_b0060","article-title":"Germline susceptibility to renal cell carcinoma and implications for genetic screening","volume":"8","author":"Glennon","year":"2024","journal-title":"JCO Precis Oncol"},{"key":"10.1016\/j.euo.2026.03.004_b0065","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.3390\/genes14111991","article-title":"Detection rate and spectrum of pathogenic variations in a cohort of 83 patients with suspected hereditary risk of kidney cancer","volume":"14","author":"Ouedraogo","year":"2023","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.euo.2026.03.004_b0070","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1097\/JU.0000000000004089","article-title":"Germline pathogenic variants identified in patients with genitourinary malignancies undergoing universal testing: a multisite single-institution prospective study","volume":"212","author":"Choudry","year":"2024","journal-title":"J Urol"},{"key":"10.1016\/j.euo.2026.03.004_b0075","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.1093\/hmg\/ddac089","article-title":"Frequency of pathogenic germline variants in cancer susceptibility genes in 1336 renal cell carcinoma cases","volume":"31","author":"Yngvadottir","year":"2022","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.euo.2026.03.004_b0080","first-page":"1962","article-title":"Different risk genes contribute to clear cell and non-clear cell renal cell carcinoma in 1532 Japanese patients and 5996 controls","volume":"31","author":"Sekine","year":"2022","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.euo.2026.03.004_b0085","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.euros.2024.02.006","article-title":"Integrative analysis of germline rare variants in clear and non-clear cell renal cell carcinoma","volume":"62","author":"Han","year":"2024","journal-title":"Eur Urol Open Sci"},{"key":"10.1016\/j.euo.2026.03.004_b0090","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1056\/NEJMsr1406261","article-title":"ClinGen\u2013the clinical genome resource","volume":"372","author":"Rehm","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.euo.2026.03.004_b0095","doi-asserted-by":"crossref","first-page":"151","DOI":"10.6004\/jnccn.2015.0022","article-title":"Kidney cancer, version 3.2015","volume":"13","author":"Motzer","year":"2015","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.euo.2026.03.004_b0100","doi-asserted-by":"crossref","first-page":"3957","DOI":"10.1002\/cncr.33679","article-title":"Genetic risk assessment for hereditary renal cell carcinoma: clinical consensus statement","volume":"127","author":"Bratslavsky","year":"2021","journal-title":"Cancer"},{"key":"10.1016\/j.euo.2026.03.004_b0105","unstructured":"Invitae. Invitae Hereditary Renal\/Urinary Tract Cancers Panel, https:\/\/www.invitae.com\/us\/providers\/test-catalog\/test-01361; Published 2025. (Accessed Sep 2025)."},{"key":"10.1016\/j.euo.2026.03.004_b0110","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1002\/cncr.31908","article-title":"Germline mutations of renal cancer predisposition genes and clinical relevance in Chinese patients with sporadic, early-onset disease","volume":"125","author":"Wu","year":"2019","journal-title":"Cancer"},{"key":"10.1016\/j.euo.2026.03.004_b0115","article-title":"Pathogenic germline mutational landscape in patients with renal cell carcinoma and associated clinicopathologic features","volume":"7","author":"Nguyen","year":"2023","journal-title":"JCO Precis Oncol"},{"key":"10.1016\/j.euo.2026.03.004_b0120","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/ng.723","article-title":"Genome-wide association study of renal cell carcinoma identifies two susceptibility loci on 2p21 and 11q13.3","volume":"43","author":"Purdue","year":"2011","journal-title":"Nat Genet"},{"key":"10.1016\/j.euo.2026.03.004_b0125","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1093\/hmg\/ddr479","article-title":"A genome-wide association study identifies a novel susceptibility locus for renal cell carcinoma on 12p11.23","volume":"21","author":"Wu","year":"2012","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.euo.2026.03.004_b0130","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1158\/1055-9965.EPI-13-0818","article-title":"A genome-wide association study of renal cell carcinoma among African Americans","volume":"23","author":"Purdue","year":"2014","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.euo.2026.03.004_b0135","doi-asserted-by":"crossref","first-page":"15724","DOI":"10.1038\/ncomms15724","article-title":"Genome-wide association study identifies multiple risk loci for renal cell carcinoma","volume":"8","author":"Scelo","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.euo.2026.03.004_b0140","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1038\/s41588-024-01725-7","article-title":"Multi-ancestry genome-wide association study of kidney cancer identifies 63 susceptibility regions","volume":"56","author":"Purdue","year":"2024","journal-title":"Nat Genet"},{"key":"10.1016\/j.euo.2026.03.004_b0145","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/s41586-018-0579-z","article-title":"The UK Biobank resource with deep phenotyping and genomic data","volume":"562","author":"Bycroft","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.euo.2026.03.004_b0150","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1158\/1055-9965.EPI-23-0558","article-title":"Kidney function and risk of renal cell carcinoma","volume":"32","author":"Alcala","year":"2023","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.euo.2026.03.004_b0155","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2023.1308738","article-title":"Personalized medicine in a community health system: the NorthShore experience","volume":"14","author":"David","year":"2023","journal-title":"Front Genet"},{"key":"10.1016\/j.euo.2026.03.004_b0160","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/jdi.14297","article-title":"Validation of GenProb-T1D and its clinical utility for differentiating types of diabetes in a biobank from a US healthcare system","volume":"16","author":"Billings","year":"2024","journal-title":"J Diabetes Investig"},{"key":"10.1016\/j.euo.2026.03.004_b0165","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1101\/gr.266486.120","article-title":"Low-pass sequencing increases the power of GWAS and decreases measurement error of polygenic risk scores compared to genotyping arrays","volume":"31","author":"Li","year":"2021","journal-title":"Genome Res"},{"key":"10.1016\/j.euo.2026.03.004_b0170","unstructured":"Clinical Genome Resource. Sequence variant interpretation. https:\/\/clinicalgenome.org\/working-groups\/sequence-variant-interpretation\/. Published 2025."},{"key":"10.1016\/j.euo.2026.03.004_b0175","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"key":"10.1016\/j.euo.2026.03.004_b0180","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/s41588-021-00783-5","article-title":"The Polygenic Score Catalog as an open database for reproducibility and systematic evaluation","volume":"53","author":"Lambert","year":"2021","journal-title":"Nat Genet"},{"key":"10.1016\/j.euo.2026.03.004_b0185","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.eururo.2024.08.029","article-title":"Abdominal noncontrast computed tomography scanning to screen for kidney cancer and other abdominal pathology within community-based computed tomography screening for lung cancer: results of the Yorkshire kidney screening trial","volume":"87","author":"Stewart","year":"2025","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2026.03.004_b0190","doi-asserted-by":"crossref","unstructured":"Rossi SH, Kitt J, Godoy A, et al. Prevalence of kidney cancer in attendees for combined lung and kidney cancer screening by computed tomography scanning. Eur Urol Oncol, in press. http:\/\/doi.org\/10.1016\/j.euo.2025.07.004.","DOI":"10.1016\/j.euo.2025.07.004"}],"container-title":["European Urology Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2588931126000635?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2588931126000635?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T20:43:33Z","timestamp":1783197813000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2588931126000635"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S2588931126000635"],"URL":"https:\/\/doi.org\/10.1016\/j.euo.2026.03.004","relation":{},"ISSN":["2588-9311"],"issn-type":[{"value":"2588-9311","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Monogenic and Polygenic Risk for Kidney Cancer in Two Large Biobanks","name":"articletitle","label":"Article Title"},{"value":"European Urology Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euo.2026.03.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V. on behalf of European Association of Urology.","name":"copyright","label":"Copyright"}]}}